Skip to main content

Table 2 Unadjusted and adjusted lifetime costs, survival, and incremental cost-effectiveness

From: Evaluating the effects of variation in clinical practice: a risk adjusted cost-effectiveness (RAC-E) analysis of acute stroke services

Hospital Observed* Incremental cost per LY gained Expected Standardized Incremental cost per LY gained
Mean costs Mean survival Mean costs Mean survival Mean costs Mean survival
B $ 16,504 6.202 Dominated by hospitals A, C & D $ 16,056 6.442 $ 449 −0.24 Dominated by hospitals A & D
C $ 16,073 7.903 Dominated by hospital D $ 15,244 8.084 $ 829 −0.18 Dominated by hospitals A & D
D $ 12,471 8.139 Dominant $ 16,855 8.088 -$ 4,384 0.05 -
A $ 15,157 7.463 Dominated by hospital D $ 14,626 7.098 $ 532 0.37 $ 15,632 (D vs. A)
  1. Costs are reported in AUD. LY indicates life years.
  2. *In line with the text, observed costs and survival incorporate predicted values beyond the observed intermediate endpoints, they are labeled as ‘observed’ values because they reflect the effects of the observed intermediate endpoints.
  3. †Standardized costs and survival are estimated as observed minus expected values.